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AMA

:   against medical advice

AW

:   anterior wall

CABG

:   coronary artery bypass grafting

HCUP

:   Healthcare Cost and Utilization Project

HMO

:   health maintenance organization

HR

:   hazard ratio

HRRP

:   hospital readmission reduction program

IABP

:   intra‐aortic balloon pump

*ICD‐9‐CM*

:   *International Classification of Diseases, Ninth Revision, Clinical Modification*

LOS

:   length of stay

MACE

:   major adverse cardiac events

NCDR

:   National Cardiovascular Data Registry

NRD

:   Nationwide Readmissions Database

PCI

:   percutaneous coronary intervention

PLVAD

:   percutaneous left ventricular assist device

SE

:   standard error

STEMI

:   ST‐segment--elevation myocardial infarction

Clinical PerspectiveWhat Is New?In this large, nationwide cohort of patients hospitalized for ST‐segment--elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention, we demonstrated that very early discharge strategy is associated with reduced readmissions and decreased overall cost in low‐risk patients.Very short discharge (length of stay 1--2 days) after primary percutaneous coronary intervention for STEMI was associated with increased 30‐day mortality compared with 3‐daylength of stay in the anterior wall (AW) STEMI group but not in the non‐AW STEMI group.Longer length of stay and readmissions were strong independent predictors of higher total costs in both patients with AW and those with non‐AW STEMI.What Are the Clinical Implications?Hospital length of stay appeared to be a marker of subsequent outcomes and total healthcare costs in patients hospitalized for STEMI undergoing primary percutaneous coronary intervention.Very early discharge after primary percutaneous coronary intervention for STEMI may represent potential strategies to decrease readmissions and to lower healthcare costs.Patients with AW STEMI need attention for very early discharge strategy considering potential increase in 30‐day mortality.

 {#jah35048-sec-0008}

Recent advances in the treatment of ST‐segment--elevation myocardial infarction (STEMI) have resulted in improved outcomes.[1](#jah35048-bib-0001){ref-type="ref"}, [2](#jah35048-bib-0002){ref-type="ref"}, [3](#jah35048-bib-0003){ref-type="ref"} However, STEMI remains a significant cause of morbidity and mortality in the United States. It is estimated that nearly \$12.1 billion US dollars were spent in 2013 for hospital care of STEMI.[4](#jah35048-bib-0004){ref-type="ref"}, [5](#jah35048-bib-0005){ref-type="ref"} Early discharge after primary percutaneous coronary intervention (PCI) for STEMI has been shown to be feasible in multiple studies.[6](#jah35048-bib-0006){ref-type="ref"}, [7](#jah35048-bib-0007){ref-type="ref"}, [8](#jah35048-bib-0008){ref-type="ref"}, [9](#jah35048-bib-0009){ref-type="ref"} However, the impact of shortening hospital length of stay (LOS) on readmission remains an important question, especially since readmission after STEMI is still an enormous economic burden to the US healthcare system.[10](#jah35048-bib-0010){ref-type="ref"}

As an effort to reduce readmissions and to improve quality of care, which can lead to significant cost reduction, the Centers for Medicare & Medicaid Services implemented the Hospital Readmission Reduction Program (HRRP) in several key diseases including acute myocardial infarction.[11](#jah35048-bib-0011){ref-type="ref"} Recent studies demonstrated that about 20% of patients are readmitted within 30 days of hospitalization after STEMI, and significant efforts have been spent on identifying factors associated with 30‐day readmissions.[12](#jah35048-bib-0012){ref-type="ref"}, [13](#jah35048-bib-0013){ref-type="ref"}, [14](#jah35048-bib-0014){ref-type="ref"} Our group recently demonstrated that 30‐day readmission after STEMI was associated with an ≈50% increase in cumulative hospital costs.[15](#jah35048-bib-0015){ref-type="ref"} Considering the recent trend of declining hospital LOS after STEMI,[16](#jah35048-bib-0016){ref-type="ref"} the association between LOS, readmissions, and costs needs to be further defined. Using the Nationwide Readmissions Database (NRD), we aimed to investigate the impact of LOS on the 30‐day readmission rates and hospital costs after PCI in patients with STEMI stratified by the location of infarct.

Methods {#jah35048-sec-0009}
=======

The data that support the findings of this study are available from the corresponding author upon reasonable request.

Data Source {#jah35048-sec-0010}
-----------

Data were obtained from the Agency for Healthcare Research and Quality, which administers the Healthcare Cost and Utilization Project (HCUP). We used NRD from 2010 to 2014. The NRD is a large administrative database constructed using discharge data from the HCUP State Inpatient Databases, with verified patient linkage numbers used to track the patients across hospitals within a state during a given year.[17](#jah35048-bib-0017){ref-type="ref"} The NRD is designed to support national readmission analyses and is a publicly available national representative healthcare database. From 2010 to 2014, the NRD contained deidentified information for total 70 501 787 index hospitalizations from 1715 to 2048 hospitals in 18 to 22 states, representing a national estimate of 181 545 077 discharges. Each patient record in the NRD contains information on the patient\'s diagnoses and procedures performed during the hospitalization based on *International Classification of Diseases, Ninth Revision, Clinical Modification* (*ICD‐9‐CM*) codes and Clinical Classification Software (CCS) codes that groups multiple *ICD‐9‐CM* codes for facilitated statistical analyses. We identified our study population, comorbidities, causes of readmissions, in‐hospital outcomes using a combination of *ICD‐9‐CM* codes, and Clinical Classification Software codes. Institutional review board approval and informed consent were not required for current study because all data collection was derived from a publicly open and deidentified administrative database.

Study Population and Variables {#jah35048-sec-0011}
------------------------------

All hospitalizations for STEMI with subsequent underwent PCI during index hospitalization were selected by finding *ICD‐9‐CM* codes for initial STEMI (410.x1) and PCI (00.66, 36.01, 36.02, 36.05, 36.06, and 36.07) (total unweighted N=228 953; weighted N=539 517). Subendocardial infarction (410.7x) was excluded from the analysis. In addition, patients who died during the index hospitalization were excluded in this cohort. To evaluate the effect of LOS and eliminate outliers, we included patients with a LOS from 1 day up to 14 days. LOS was calculated by subtracting the admission date from the discharge date. The LOS was categorized as follows: short LOS (LOS 1--3 days), medium LOS (LOS 4--5 days), and long LOS (LOS \>5 days). We also examined the very short LOS (LOS 1--2 days) cohort versus those with a longer LOS after subdividing patients into 5 LOS cohorts (LOS 1--2, 3, 4, 5, and \>5).

Patients with a concomitant diagnosis of cardiogenic shock and cardiac arrest were identified using *ICM‐9‐CM* codes 785.51 and 427.5, respectively. Concurrent use of intra‐aortic balloon pump and percutaneous left ventricular assist devices were identified with *ICD‐9‐CM* procedure codes 37.61 and 37.68, respectively. Since NRD prohibits linking patients across years, patients discharged from January through November were included in the study to allow for completeness of data on 30 days of follow‐up after discharge. Furthermore, patients with missing data on LOS were excluded to properly capture interval until readmission. Patient‐ and hospital‐level variables were included as baseline characteristics. NRD variables were used to identify age, sex, median household income quartiles, primary payer, hospital teaching status, location, and bed size. *ICD‐9‐CM* codes for selected concurrent clinical diagnoses and procedures are listed in [Table S1](#jah35048-sup-0001){ref-type="supplementary-material"}.

Study Outcomes {#jah35048-sec-0012}
--------------

The primary outcome of this study was 30‐day readmission rate described by the HCUP. Time to readmission was defined as the number of days from discharge date of index admission to readmission date. The first readmission in 30 days was included, and transfer to another hospital was not counted as a readmission. The secondary outcomes within 30 days included rates of all‐cause mortality, reinfarction (*ICD‐9‐CM* codes of 410.x1 except 410.7x), repeat revascularization, and major adverse cardiac events (MACE), defined as a composite of mortality, reinfarction, and repeat revascularization. Furthermore, cumulative hospital charges and costs for index hospitalizations and readmissions were examined according to LOS.

Statistical Analyses {#jah35048-sec-0013}
--------------------

All statistical analyses were performed using SAS software version 9.4 (SAS Institute Inc) and R statistical software version 3.5.1 ([www.R-proje​ct.org](http://www.R-project.org)) with its package "survey." Discharge weight and stratum provided by NRD were used for all analyses and thus all reported numbers are weighted national estimates.[17](#jah35048-bib-0017){ref-type="ref"} Domain analysis was used for accurate variance calculations for subgroup analyses.[18](#jah35048-bib-0018){ref-type="ref"} All analyses accounted for NRD sampling design by including hospital‐year fixed effects based on hospital identification number.[19](#jah35048-bib-0019){ref-type="ref"} We compared baseline patient‐ and hospital‐level characteristics with STEMI and PCI stratified by the occurrence of 30‐day readmission, LOS, and location of the infarct. Categorical variables are presented as frequencies and analyzed by Rao‐Scott chi‐square test. Continuous variables are shown as mean or median and were tested by either Mann--Whitney--Wilcoxon test or survey‐specific linear regression test. To evaluate the predictive value of LOS and other covariates for primary and secondary outcomes, survey‐specific univariate and multivariable Cox proportional hazards models were applied. Variables with *P*\<0.1 were included as initial covariates. Final parsimonious models were created by manual removal of each covariate based on Akaike information criterion while ensuring each removal did not result in \>10% change in the measure of association for the primary predictor variable. Adjusted risks are presented as hazard ratios (HRs) together with 95% CIs and *P* values. For the cost analysis, the estimated cost for each hospitalization was calculated by the validated method of using cost‐to‐charge ratio provided by HCUP.[20](#jah35048-bib-0020){ref-type="ref"} NRD data was merged with cost‐to‐charge ratio files provided by HCUP and then multiplied by the charge for each hospitalization with the respective cost‐to‐charge ratio. Cumulative total cost was defined as the cost of readmission plus the cost of the index admission. Afterward, we examined the predictors of cumulative cost by performing survey‐specific multivariable linear regression test and log‐transforming costs to achieve a normal distribution. All tests were 2‐sided with *P*\<0.05 considered statistically significant.

Results {#jah35048-sec-0014}
=======

Baseline Characteristics by LOS {#jah35048-sec-0015}
-------------------------------

During the study period, 539 517 patients underwent primary PCI after STEMI at 3682 sites. Overall, 187 557 patients (34.8%) presented with anterior wall (AW) STEMI, while 351 960 patients (65.2%) presented with non‐AW (NAW) STEMI. The mean age was 60.8 years (standard error, 0.1) in the AW STEMI group and 61.2 years (standard error, 0.1) in the NAW STEMI group. The distribution of LOS in the overall patients, AW STEMI group, and NAW STEMI group is shown in Figure [1](#jah35048-fig-0001){ref-type="fig"}. Patients with AW STEMI were more likely to stay longer in the hospital than those with NAW STEMI (LOS mean±standard error: 3.7±0.1 versus 3.3±0.1; *P*\<0.001). The proportion of patients in each LOS cohort was 69.7% (n=375 996) for short LOS, 17.6% (n=94 936) for medium LOS, and 12.7% (n=68 583) for long LOS. Among those who presented with AW STEMI, the proportion of each LOS cohort was 62.6% (n=117 332) for short LOS, 21.4% (n=40 232) for medium LOS, and 16.0% (n=29 993) for long LOS. In the NAW STEMI group, the proportion was 73.5% (n=258 663) for short LOS, 15.5% (n=54 706) for medium LOS, and 11.0% (n=38 591) for long LOS.

![Histogram of length of hospital stay.\
**A**, Density of length of stay (LOS) in overall patients. **B**, Density of LOS in patients with anterior wall (AW) myocardial infarction. **C**, Density of LOS in patients with non‐AW myocardial infarction.](JAH3-9-e015503-g001){#jah35048-fig-0001}

Tables [1](#jah35048-tbl-0001){ref-type="table"} and [2](#jah35048-tbl-0002){ref-type="table"} compare the baseline patient‐ and hospital‐level characteristics according to LOS groups stratified by 30‐day readmission. Patients in the medium or long LOS cohort were older and more likely to be women and have hypertension, diabetes mellitus, previous myocardial infarction, previous coronary artery bypass graft surgery, family history of coronary artery disease, congestive heart failure, peripheral vascular disorders, chronic pulmonary disease, chronic kidney disease, liver disease, anemia, atrial fibrillation, coagulopathy, cerebrovascular disease, fluid and electrolyte disorders, obesity, and other neurological disorders compared with the short LOS cohort in both AW and NAW STEMI groups ([Table S2](#jah35048-sup-0001){ref-type="supplementary-material"}). In addition, patients in the medium or long LOS cohort were more likely to have concomitant cardiogenic shock or cardiac arrest and require support from intraaortic balloon pump or percutaneous left ventricular assist device in both the AW and NAW STEMI groups.

###### 

Baseline Characteristics for Patients Discharged Alive After Index Hospitalization With STEMI in AW

  Characteristics                                   Overall                                                 LOS 1 to 3 d    LOS 4 to 5 d                                     LOS \>5 d                                                                                                                                                                                     
  ------------------------------------------------- ------------------------------------------------------- --------------- ------------------------------------------------ ---------------- -------------- ------------------------------------------------ --------------- ------------- ------------------------------------------------ --------------- ------------- ------------------------------------------------
  Patients, No.                                     165 024 (88.0)[a](#jah35048-note-0004){ref-type="fn"}   22 533 (12.0)                                                    107 122 (91.3)   10 210 (8.7)                                                    34 251 (85.1)   5981 (14.9)                                                    23 651 (78.9)   6342 (21.1)   
  Patient characteristics                                                                                                                                                                                                                                                                                                                                                  
  Age, mean (SE), y                                 60.3 (0.1)                                              64.3 (0.2)      \<0.001[b](#jah35048-note-0005){ref-type="fn"}   59.0 (0.1)       62.2 (0.3)     \<0.001[b](#jah35048-note-0005){ref-type="fn"}   61.7 (0.2)      64.9 (0.3)    \<0.001[b](#jah35048-note-0005){ref-type="fn"}   64.3 (0.2)      67.6 (0.3)    \<0.001[b](#jah35048-note-0005){ref-type="fn"}
  Age group, y                                                                                                              \<0.001[c](#jah35048-note-0006){ref-type="fn"}                                   \<0.001                                                                        \<0.001                                                                        \<0.001
  \<50                                              33 283 (20.2)                                           3476 (15.4)                                                      23 544 (22.0)    1841 (18.0)                                                     6356 (18.6)     957 (16.0)                                                     3383 (14.3)     679 (10.7)    
  50 to 64                                          73 823 (44.7)                                           7953 (35.3)                                                      50 748 (47.4)    4023 (39.4)                                                     14 263 (41.6)   2021 (33.8)                                                    8812 (37.3)     1909 (30.1)   
  ≥65                                               57 918 (35.1)                                           11 103 (49.3)                                                    32 831 (30.6)    4346 (42.6)                                                     13 631 (39.8)   3004 (50.2)                                                    11 456 (48.4)   3754 (59.2)   
  Women                                             41 087 (24.9)                                           7941 (35.2)     \<0.001                                          23 239 (21.7)    3108 (30.4)    \<0.001                                          9975 (29.1)     2273 (38.0)   \<0.001                                          7874 (33.3)     2561 (40.4)   \<0.001
  Smoking history                                   77 606 (47.0)                                           10 090 (44.8)   \<0.001                                          52 876 (49.4)    4944 (48.4)    0.320                                            15 444 (45.1)   2685 (44.9)   0.877                                            9286 (39.3)     2461 (38.8)   0.709
  Hypertension                                      100 897 (61.1)                                          15 186 (67.4)   \<0.001                                          64 681 (60.4)    6702 (65.6)    \<0.001                                          21 256 (62.1)   4123 (68.9)   \<0.001                                          14 960 (63.3)   4361 (68.8)   \<0.001
  Diabetes mellitus                                 38 147 (23.1)                                           6367 (28.3)     \<0.001                                          23 266 (21.7)    2692 (26.4)    \<0.001                                          8700 (25.4)     1725 (28.8)   0.003                                            6182 (26.1)     1950 (30.8)   \<0.001
  Dyslipidemia                                      94 442 (57.2)                                           12 791 (56.8)   0.494                                            62 864 (58.7)    5985 (58.6)    0.945                                            19 381 (56.6)   3388 (56.6)   0.961                                            12 197 (51.6)   3418 (53.9)   0.058
  Known coronary artery disease                     144 171 (87.4)                                          19 748 (87.6)   0.531                                            93 590 (87.4)    8951 (87.7)    0.623                                            30 057 (87.8)   5279 (88.3)   0.525                                            20 525 (86.8)   5518 (87.0)   0.809
  Previous myocardial infarction                    10 962 (6.6)                                            1844 (8.2)      \<0.001                                          7123 (6.6)       802 (7.9)      0.011                                            2141 (6.3)      497 (8.3)     \<0.001                                          1698 (7.2)      544 (8.6)     0.030
  Previous PCI                                      17 522 (10.6)                                           2744 (12.2)     \<0.001                                          11 277 (10.5)    1212 (11.9)    0.018                                            3515 (10.3)     760 (12.7)    0.002                                            2731 (11.5)     773 (12.2)    0.414
  Previous CABG                                     1664 (1.0)                                              384 (1.7)       \<0.001                                          969 (0.9)        157 (1.5)      \<0.001                                          349 (1.0)       104 (1.7)     0.005                                            346 (1.5)       123 (1.9)     0.149
  Family history of coronary artery disease         22 363 (13.6)                                           2421 (10.7)     \<0.001                                          15 896 (14.8)    1288 (12.6)    \<0.001                                          4310 (12.6)     670 (11.2)    0.126                                            2158 (9.1)      464 (7.3)     0.017
  Congestive heart failure                          28 063 (17.0)                                           6452 (28.6)     \<0.001                                          9266 (8.6)       1300 (12.7)    \<0.001                                          8076 (23.6)     1809 (30.2)   \<0.001                                          10 721 (45.3)   3343 (52.7)   \<0.001
  Peripheral vascular disease                       8059 (4.9)                                              1867 (8.3)      \<0.001                                          3925 (3.7)       635 (6.2)      \<0.001                                          2053 (6.0)      468 (7.8)     0.002                                            2081 (8.8)      763 (12.0)    \<0.001
  Chronic pulmonary disease                         17 866 (10.8)                                           3833 (17.0)     \<0.001                                          9539 (8.9)       1329 (13.0)    \<0.001                                          4155 (12.1)     1045 (17.5)   \<0.001                                          4172 (17.6)     1458 (23.0)   \<0.001
  Chronic kidney disease                            9496 (5.8)                                              2828 (12.6)     \<0.001                                          3924 (3.7)       727 (7.1)      \<0.001                                          2352 (6.9)      756 (12.6)    \<0.001                                          3221 (13.6)     1346 (21.2)   \<0.001
  Liver disease                                     1462 (0.9)                                              240 (1.1)       0.120                                            824 (0.8)        95 (0.9)       0.305                                            294 (0.9)       71 (1.2)      0.168                                            344 (1.5)       74 (1.2)      0.226
  Anemia                                            10 506 (6.4)                                            2832 (12.6)     \<0.001                                          3249 (3.0)       622 (6.1)      \<0.001                                          2781 (8.1)      728 (12.2)    \<0.001                                          4476 (18.9)     1483 (23.4)   \<0.001
  Atrial fibrillation                               12 878 (7.8)                                            3479 (15.4)     \<0.001                                          4336 (4.0)       816 (8.0)      \<0.001                                          3632 (10.6)     957 (16.0)    \<0.001                                          4911 (20.8)     1705 (26.9)   \<0.001
  Coagulopathy                                      4293 (2.6)                                              848 (3.8)       \<0.001                                          1341 (1.3)       173 (1.7)      0.023                                            971 (2.8)       178 (3.0)     0.713                                            1981 (8.4)      497 (7.8)     0.459
  Collagen vascular disease                         2931 (1.8)                                              569 (2.5)       \<0.001                                          1675 (1.6)       184 (1.8)      0.288                                            683 (2.0)       152 (2.5)     0.201                                            572 (2.4)       233 (3.7)     0.001
  Drug abuse                                        4817 (2.9)                                              804 (3.6)       0.002                                            3064 (2.9)       377 (3.7)      0.006                                            1039 (3.0)      209 (3.5)     0.258                                            714 (3.0)       217 (3.4)     0.386
  Fluid/electrolyte disorders                       20 705 (12.5)                                           4097 (18.2)     \<0.001                                          8201 (7.7)       1032 (10.1)    \<0.001                                          8182 (15.1)     917 (15.3)    0.821                                            7322 (31.0)     2149 (33.9)   0.016
  Obesity                                           22 433 (13.6)                                           2902 (12.9)     0.111                                            14 366 (13.4)    1259 (12.3)    0.129                                            4628 (13.5)     772 (12.9)    0.463                                            3439 (14.5)     870 (13.7)    0.374
  Other neurological disorders                      4791 (2.9)                                              1037 (4.6)      \<0.001                                          2223 (2.1)       331 (3.2)      \<0.001                                          1185 (3.5)      278 (4.6)     0.014                                            1384 (5.9)      429 (6.8)     0.122
  Median household income                                                                                                   \<0.001                                                                          0.009                                                                          0.011                                                                          0.557
  First quartile                                    45 601 (28 2)                                           6801 (30.7)                                                      28 807 (27.4)    2989 (29.7)                                                     9777 (29.1)     1834 (31.2)                                                    7027 (30.3)     1978 (31.9)   
  Second quartile                                   42 951 (26.5)                                           6003 (27.1)                                                      27 946 (26.6)    2756 (27.4)                                                     8888 (26.4)     1639 (27.9)                                                    6117 (26.4)     1608 (25.9)   
  Third quartile                                    39 131 (24.2)                                           5113 (23.1)                                                      25 613 (24.4)    2317 (23.1)                                                     8090 (24.0)     1403 (23.8)                                                    5427 (23.4)     1393 (22.5)   
  Fourth quartile                                   34 165 (21.1)                                           4222 (19.1)                                                      22 659 (21.6)    1989 (19.8)                                                     6884 (20.5)     1009 (17.1)                                                    4621 (19.9)     1225 (19.7)   
  Primary payer                                                                                                             \<0.001                                                                          \<0.001                                                                        \<0.001                                                                        \<0.001
  Medicare                                          59 249 (35.9)                                           11 581 (51.4)                                                    33 937 (31.7)    4618 (45.2)                                                     13 858 (40.5)   3113 (52.1)                                                    11 453 (48.4)   3849 (60.7)   
  Medicaid                                          12 619 (7.6)                                            2225 (9.9)                                                       7639 (7.1)       975 (9.6)                                                       2881 (8.4)      623 (10.4)                                                     2099 (8.9)      627 (9.9)     
  Private including HMO                             65 646 (39.8)                                           5970 (26.5)                                                      46 446 (43.4)    3235 (31.7)                                                     12 291 (35.9)   1507 (25.2)                                                    6910 (29.2)     1228 (19.4)   
  Self‐pay/no charge/other                          27 510 (16.7)                                           2757 (12.2)                                                      19 101 (17.8)    1381 (13.5)                                                     5220 (15.2)     737 (12.3)                                                     3189 (13.5)     639 (10.1)    
  Index STEMI presentation/treatment                                                                                                                                                                                                                                                                                                                                       
  Weekend admission                                 48 189 (29.2)                                           6272 (27.8)     0.016                                            31 794 (29.7)    2875 (28.2)    0.083                                            10 326 (30.1)   1811 (30.3)   0.908                                            6070 (25.7)     1587 (25.0)   0.548
  Cardiogenic shock                                 11 189 (6.8)                                            2532 (11.2)     \<0.001                                          1847 (1.7)       247 (2.4)      0.003                                            2611 (7.6)      546 (9.1)     0.023                                            6723 (28.4)     1738 (27.4)   0.387
  Cardiac arrest                                    6675 (4.0)                                              1030 (4.6)      0.058                                            1987 (1.9)       213 (2.1)      0.366                                            1672 (4.9)      274 (4.6)     0.624                                            3017 (12.8)     543 (8.6)     \<0.001
  IABP                                              13 261 (8.0)                                            2818 (12.5)     \<0.001                                          2193 (2.0)       306 (3.0)      \<0.001                                          4167 (12.2)     770 (12.9)    0.398                                            6901 (29.2)     1742 (27.5)   0.121
  PLVAD                                             565 (0.3)                                               114 (0.5)       0.041                                            86 (0.1)         12 (0.1)       0.484                                            100 (0.3)       15 (0.3)      0.750                                            380 (1.6)       87 (1.4)      0.451
  Hospital characteristics                                                                                                                                                                                                                                                                                                                                                 
  Hospital teaching status                                                                                                  0.210                                                                            0.011                                                                          0.055                                                                          0.661
  Teaching                                          88 606 (53.7)                                           11 905 (52.8)                                                    55 994 (52.3)    5083 (49.8)                                                     19 335 (56.5)   3228 (54.0)                                                    13 277 (56.1)   3595 (56.7)   
  Nonteaching                                       76 418 (46.3)                                           10 627 (47.2)                                                    51 129 (47.7)    5126 (50.2)                                                     14 915 (43.5)   2753 (46.0)                                                    10 374 (43.9)   2747 (43.3)   
  Hospital location                                                                                                         \<0.001                                                                          0.193                                                                          0.449                                                                          0.037
  Rural                                             85 571 (51.9)                                           11 146 (49.5)                                                    56 907 (53.1)    5293 (51.8)                                                     17 207 (50.2)   2945 (49.2)                                                    11 458 (48.4)   2907 (45.8)   
  Urban                                             79 453 (48.1)                                           11 387 (50.5)                                                    50 216 (46.9)    4916 (48.2)                                                     17 044 (49.8)   3036 (50.8)                                                    12 192 (51.6)   3434 (54.2)   
  Hospital bed size                                                                                                         0.019                                                                            0.399                                                                          0.536                                                                          0.222
  Small                                             11 889 (7.2)                                            1399 (6.2)                                                       8081 (7.5)       702 (6.9)                                                       2302 (6.7)      363 (6.1)                                                      1506 (6.4)      334 (5.3)     
  Medium                                            36 686 (22.2)                                           4920 (21.8)                                                      24 707 (23.1)    2426 (23.8)                                                     7356 (21.5)     1239 (20.7)                                                    4623 (19.5)     1254 (19.8)   
  Large                                             116 449 (70.6)                                          16 213 (72.0)                                                    74 335 (69.4)    7081 (69.4)                                                     24 593 (71.8)   4379 (73.2)                                                    17 521 (74.1)   4753 (75.0)   
  Disposition                                                                                                               \<0.001                                                                          \<0.001                                                                        \<0.001                                                                        \<0.001
  Home                                              147 108 (89.1)                                          17 367 (77.1)                                                    102 366 (95.6)   9219 (90.3)                                                     29 771 (86.9)   4697 (78.5)                                                    14 971 (63.3)   3450 (54.4)   
  Facility[d](#jah35048-note-0007){ref-type="fn"}   16 908 (10.2)                                           4950 (22.0)                                                      3918 (3.7)       854 (8.4)                                                       4385 (12.8)     1233 (20.6)                                                    8605 (36.4)     2863 (45.1)   
  AMA/unknown                                       1008 (0.6)                                              215 (1.0)                                                        838 (0.8)        136 (1.3)                                                       95 (0.3)        51 (0.9)                                                       75 (0.3)        29 (0.5)      

AMA indicates against medical advice; AW, anterior wall; CABG, coronary artery bypass grafting; HMO, health maintenance organization; IABP, intra‐aortic balloon pump; LOS, length of stay; PCI, percutaneous coronary intervention; PLVAD, percutaneous left ventricular assist device; SE, standard error; and STEMI, ST‐segment--elevation myocardial infarction.

Values are presented as number (percentage) of patients unless otherwise indicated.

Survey‐specific linear regression was performed.

Rao‐Scott chi‐square test was used for all statistical tests unless stated otherwise.

Facility includes skilled nursing facility, intermediate care facility, and inpatient rehabilitation facility.

John Wiley & Sons, Ltd

###### 

Baseline Characteristics for Patients Discharged Alive After Index Hospitalization with STEMI in Nonanterior Wall

  Characteristics                                   Overall                                                 LOS 1 to 3 d    LOS 4 to 5 d                                     LOS \>5 d                                                                                                                                                                                      
  ------------------------------------------------- ------------------------------------------------------- --------------- ------------------------------------------------ ---------------- --------------- ------------------------------------------------ --------------- ------------- ------------------------------------------------ --------------- ------------- ------------------------------------------------
  Patients, No.                                     317 076[a](#jah35048-note-0009){ref-type="fn"} (90.1)   34 883 (9.9)                                                     238 624 (92.3)   20 040 (7.7)                                                     47 395 (86.6)   7310 (13.4)                                                    31 058 (80.5)   7533 (19.5)   
  Patient characteristics                                                                                                                                                                                                                                                                                                                                                   
  Age, mean (SE), y                                 60.9 (0.1)                                              64.4 (0.1)      \<0.001[b](#jah35048-note-0010){ref-type="fn"}   59.7 (0.1)       62.2 (0.2)      \<0.001[b](#jah35048-note-0010){ref-type="fn"}   63.6 (0.1)      66.3 (0.3)    \<0.001[b](#jah35048-note-0010){ref-type="fn"}   65.9 (0.1)      68.3 (0.3)    \<0.001[b](#jah35048-note-0010){ref-type="fn"}
  Age group, y                                                                                                              \<0.001[c](#jah35048-note-0011){ref-type="fn"}                                    \<0.001                                                                        \<0.001                                                                        \<0.001
  \<50                                              56 533 (17.8)                                           4861 (13.9)                                                      46 821 (19.6)    3491 (17.4)                                                      6627 (14.0)     833 (11.4)                                                     8085 (9.9)      538 (7.1)     
  50 to 64                                          144 000 (45.4)                                          12 817 (36.7)                                                    113 218 (47.4)   8028 (40.1)                                                      19 283 (40.7)   2420 (33.1)                                                    11 500 (37.0)   2368 (31.4)   
  ≥65                                               116 544 (36.8)                                          17 205 (49.3)                                                    78 585 (32.9)    8520 (42.5)                                                      21 486 (45.3)   4058 (55.5)                                                    16 473 (0.53)   4627 (61.4)   
  Women                                             87 055 (27.5)                                           12 980 (37.2)   \<0.001                                          59 996 (25.1)    5521 (33.1)     \<0.001                                          16 024 (33.8)   3065 (41.9)   \<0.001                                          11 034 (35.5)   3282 (43.6)   \<0.001
  Smoking history                                   165 955 (52.3)                                          16 289 (46.7)   \<0.001                                          130 523 (54.7)   10 113 (50.5)   \<0.001                                          22 398 (47.3)   3192 (43.7)   0.002                                            13 034 (42.0)   2985 (39.6)   0.053
  Hypertension                                      204 951 (64.6)                                          24 543 (70.4)   \<0.001                                          151 781 (63.6)   13 912 (69.4)   \<0.001                                          31 918 (67.3)   5274 (72.1)   \<0.001                                          21 252 (68.4)   5357 (71.1)   0.016
  Diabetes mellitus                                 74 376 (23.5)                                           10 130 (29.0)   \<0.001                                          52 890 (22.2)    5449 (27.2)     \<0.001                                          12 590 (26.6)   2279 (31.2)   \<0.001                                          8897 (28.6)     2402 (31.9)   0.004
  Dyslipidemia                                      189 949 (59.9)                                          20 014 (57.4)   \<0.001                                          145 164 (60.8)   11 911 (59.4)   0.038                                            27 933 (58.9)   4183 (57.2)   0.119                                            16 852 (54.3)   3920 (52.0)   0.061
  Known coronary artery disease                     274 434 (86.6)                                          30 088 (86.3)   0.408                                            206 436 (86.5)   17 322 (86.4)   0.879                                            41 391 (87.3)   6317 (86.4)   0.233                                            26 607 (85.7)   6448 (85.6)   0.934
  Previous myocardial infarction                    26 016 (8.2)                                            3117 (8.9)      0.015                                            19 196 (8.0)     1692 (8.4)      0.297                                            4117 (8.7)      714 (9.8)     0.093                                            2703 (8.7)      712 (9.5)     0.294
  Previous PCI                                      41 118 (13.0)                                           4895 (14.0)     0.004                                            30 853 (12.9)    2754 (13.7)     0.088                                            6080 (12.8)     1023 (14.0)   0.142                                            4185 (13.5)     1118 (14.8)   0.103
  Previous CABG                                     9875 (3.1)                                              1338 (3.8)      \<0.001                                          6961 (2.9)       679 (3.4)       0.057                                            1721 (3.6)      282 (3.9)     0.594                                            1193 (3.8)      377 (5.0)     0.020
  Family history of coronary artery disease         42 565 (13.4)                                           3669 (10.5)     \<0.001                                          34 591 (14.5)    2531 (12.6)     \<0.001                                          5200 (11.0)     634 (8.7)     0.002                                            2773 (8.9)      505 (6.7)     \<0.001
  Congestive heart failure                          24 943 (7.9)                                            5895 (16.9)     \<0.001                                          9634 (4.0)       1503 (7.5)      \<0.001                                          5990 (12.6)     1619 (22.1)   \<0.001                                          9319 (30.0)     2772 (36.8)   \<0.001
  Peripheral vascular disease                       20 194 (6.4)                                            3605 (10.3)     \<0.001                                          12 438 (5.2)     1536 (7.7)      \<0.001                                          4047 (8.5)      931 (12.7)    \<0.001                                          3709 (11.9)     1138 (15.1)   \<0.001
  Chronic pulmonary disease                         40 035 (12.6)                                           6846 (19.6)     \<0.001                                          25 818 (10.8)    3304 (16.5)     \<0.001                                          7466 (15.8)     1572 (21.5)   \<0.001                                          6750 (21.7)     1969 (26.1)   \<0.001
  Chronic kidney disease                            18 808 (5.9)                                            4513 (12.9)     \<0.001                                          9624 (4.0)       1647 (8.2)      \<0.001                                          4159 (8.8)      1099 (15.0)   \<0.001                                          5025 (16.2)     1767 (23.5)   \<0.001
  Liver disease                                     2883 (0.9)                                              478 (1.4)       \<0.001                                          1803 (0.8)       235 (1.2)       \<0.001                                          562 (1.2)       100 (1.4)     0.413                                            518 (1.7)       143 (1.9)     0.442
  Anemia                                            20 972 (6.6)                                            4780 (13.7)     \<0.001                                          8928 (3.7)       1486 (7.4)      \<0.001                                          5100 (10.8)     1240 (17.0)   \<0.001                                          6944 (22.4)     2053 (27.3)   \<0.001
  Atrial fibrillation                               25 715 (8.1)                                            5038 (14.4)     \<0.001                                          12 801 (5.4)     1695 (8.5)      \<0.001                                          5933 (12.5)     1362 (18.6)   \<0.001                                          6981 (22.5)     1981 (26.3)   \<0.001
  Coagulopathy                                      7280 (2.3)                                              1204 (3.5)      \<0.001                                          2899 (1.2)       294 (1.5)       0.082                                            1488 (3.1)      268 (3.7)     0.212                                            2893 (9.3)      642 (8.5)     0.267
  Collagen vascular disease                         5857 (1.8)                                              915 (2.6)       \<0.001                                          3965 (1.7)       422 (2.1)       0.010                                            1186 (2.5)      254 (3.5)     0.012                                            705 (2.3)       240 (3.2)     0.018
  Drug abuse                                        8306 (2.6)                                              991 (2.8)       0.161                                            6181 (2.6)       663 (3.3)       \<0.001                                          1304 (2.8)      204 (2.8)     0.933                                            820 (2.6)       124 (1.6)     0.001
  Fluid/electrolyte disorders                       33 047 (10.4)                                           5801 (16.6)     \<0.001                                          16 251 (6.8)     1738 (8.7)      \<0.001                                          6839 (14.4)     1366 (18.7)   \<0.001                                          9957 (32.1)     2697 (35.8)   \<0.001
  Obesity                                           44 435 (14.0)                                           4886 (14.0)     0.982                                            32 872 (13.8)    2695 (13.4)     0.483                                            6770 (14.3)     1014 (13.9)   0.631                                            4794 (15.4)     1177 (15.6)   0.822
  Other neurological disorders                      8686 (2.7)                                              1597 (4.6)      \<0.001                                          5182 (2.2)       714 (3.6)       \<0.001                                          1625 (3.4)      314 (4.3)     0.026                                            1880 (6.1)      569 (7.6)     0.026
  Median household income                                                                                                   \<0.001                                                                           \<0.001                                                                        0.109                                                                          0.235
  First quartile                                    91 316 (29.3)                                           10 926 (31.9)                                                    67 466 (28.8)    6 1162 (31.3)                                                    14 530 (31.2)   2386 (33.2)                                                    9320 (30.6)     2379 (32.1)   
  Second quartile                                   83 375 (26.8)                                           9046 (26.4)                                                      63 116 (26.9)    5199 (26.4)                                                      12 159 (26.1)   1823 (25.4)                                                    8100 (26.6)     2024 (27.3)   
  Third quartile                                    76 278 (24.5)                                           8163 (23.8)                                                      57 915 (24.7)    4702 (23.9)                                                      10 977 (23.6)   1729 (24.1)                                                    7386 (24.2)     1732 (23.4)   
  Fourth quartile                                   60 361 (19.4)                                           6150 (17.9)                                                      45 809 (19.6)    3634 (18.4)                                                      8878 (19.1)     1241 (17.3)                                                    5673 (18.6)     1275 (17.2)   
  Primary payer                                                                                                             \<0.001                                                                           \<0.001                                                                        \<0.001                                                                        \<0.001
  Medicare                                          121 138 (38.2)                                          18 413 (52.8)                                                    82 427 (34.5)    9219 (46.0)                                                      22 094 (46.6)   4363 (59.7)                                                    16 618 (53.5)   4831 (64.1)   
  Medicaid                                          21 603 (6.8)                                            2926 (8.4)                                                       15 700 (6.6)     1651 (8.2)                                                       3456 (7.3)      603 (8.2)                                                      2447 (7.9)      671 (8.9)     
  Private including HMO                             122 511 (38.6)                                          9529 (27.3)                                                      99 520 (41.7)    6463 (32.3)                                                      14 681 (31.0)   1619 (22.1)                                                    8309 (26.8)     1448 (19.2)   
  Self‐pay/no charge/other                          51 824 (16.3)                                           4015 (11.5)                                                      40.977 (17.2)    2706 (13.5)                                                      7164 (15.1)     725 (9.9)                                                      3683 (11.9)     583 (7.7)     
  Index STEMI presentation/treatment                                                                                                                                                                                                                                                                                                                                        
  Weekend admission                                 90 651 (28.6)                                           9770 (28.0)     0.219                                            69 034 (28.9)    5665 (28.3)     0.304                                            13 662 (28.8)   2300 (31.5)   0.013                                            7955 (25.6)     1804 (23.9)   0.118
  Cardiogenic shock                                 15 204 (4.8)                                            3038 (8.7)      \<0.001                                          4546 (1.9)       533 (2.7)       \<0.001                                          3641 (7.7)      703 (9.6)     0.003                                            7017 (22.6)     1801 (23.9)   0.213
  Cardiac arrest                                    9423 (3.0)                                              1343 (3.8)      \<0.001                                          3415 (1.4)       308 (1.5)       0.505                                            2188 (4.6)      317 (4.3)     0.590                                            3820 (12.3)     717 (9.5)     \<0.001
  IABP                                              11 736 (3.7)                                            2346 (6.7)      \<0.001                                          2077 (0.9)       307 (1.5)       \<0.001                                          3 3778 (7.1)    590 (8.1)     0.124                                            6282 (20.2)     1450 (19.2)   0.348
  PLVAD                                             301 (0.1)                                               74 (0.2)        \<0.001                                          41 (0.0)         8 (0.0)         0.109                                            62 (0.1)        5 (0.1)       0.305                                            198 (0.6)       60 (0.8)      0.398
  Hospital characteristics                                                                                                                                                                                                                                                                                                                                                  
  Hospital teaching status                                                                                                  0.312                                                                             0.133                                                                          0.784                                                                          0.234
  Teaching                                          166 974 (52.7)                                          18 158 (52.1)                                                    124 444 (52.2)   10 217 (51.0)                                                    25 442 (53.7)   3901 (53.4)                                                    17 089 (55.0)   4040 (53.6)   
  Nonteaching                                       150 102 (47.3)                                          16 725 (47.9)                                                    114 179 (47.8)   9822 (49.0)                                                      21 954 (46.3)   3410 (46.6)                                                    13 969 (45.0)   3493 (46.4)   
  Hospital location                                                                                                         \<0.001                                                                           \<0.001                                                                        0.698                                                                          0.019
  Rural                                             167 549 (52.8)                                          17 352 (49.7)                                                    128 909 (54.0)   10 295 (51.4)                                                    23 502 (49.6)   3591 (49.1)                                                    15 138 (48.7)   3466 (46.0)   
  Urban                                             149 527 (47.2)                                          17 532 (50.3)                                                    109 714 (46.0)   9744 (48.6)                                                      23 893 (50.4)   3719 (50.9)                                                    15 920 (51.3)   4068 (54.0)   
  Hospital bed size                                                                                                         0.973                                                                             0.775                                                                          0.052                                                                          0.729
  Small                                             22 403 (7.1)                                            2458 (7.0)                                                       17 761 (7.4)     1446 (7.2)                                                       2806 (5.9)      530 (7.2)                                                      1836 (5.9)      482 (6.4)     
  Medium                                            69 610 (22.0)                                           7699 (22.1)                                                      53 459 (22.4)    4572 (22.8)                                                      10 140 (21.4)   1675 (22.9)                                                    6012 (19.4)     1452 (19.3)   
  Large                                             225 064 (71.0)                                          24 727 (70.9)                                                    167 404 (70.2)   14 021 (70.0)                                                    34 450 (72.7)   5106 (69.8)                                                    23 210 (74.7)   5599 (74.3)   
  Disposition                                                                                                               \<0.001                                                                           \<0.001                                                                        \<0.001                                                                        \<0.001
  Home                                              288 522 (91.0)                                          27 786 (79.7)                                                    228 831 (95.9)   18 249 (91.1)                                                    41 064 (86.6)   5725 (78.3)                                                    18 627 (60.0)   3812 (50.6)   
  Facility[d](#jah35048-note-0012){ref-type="fn"}   26 610 (8.4)                                            6741 (19.3)                                                      8113 (3.4)       1526 (7.6)                                                       6171 (13.0)     1539 (21.1)                                                    12 326 (39.7)   3676 (48.8)   
  AMA/unknown                                       1945 (0.6)                                              357 (1.0)                                                        1679 (0.7)       265 (1.3)                                                        161 (0.3)       46 (0.6)                                                       105 (0.3)       46 (0.6)      

AMA indicates against medical advice; CABG, coronary artery bypass grafting; HMO, health maintenance organization; IABP, intra‐aortic balloon pump; LOS, length of stay; PCI, percutaneous coronary intervention; PLVAD, percutaneous left ventricular assist device; SE, standard error; and STEMI, ST‐segment--elevation myocardial infarction.

Values are presented as number (percentage) of patients unless otherwise indicated.

Survey‐specific linear regression was performed.

Rao‐Scott chi‐square test was used for all statistical tests unless stated otherwise.

Facility includes skilled nursing facility, intermediate care facility, and inpatient rehabilitation facility.

John Wiley & Sons, Ltd

Thirty‐Day Readmission by LOS {#jah35048-sec-0016}
-----------------------------

Overall incidence of 30‐day readmission was higher in patients with AW STEMI than those with NAW STEMI (12.3% versus 9.9%, *P*\<0.001). The rates of 30‐day readmission in patients with AW STEMI were 8.7% in the short LOS cohort, 14.9% in the medium LOS cohort, and 21.1% in the long LOS cohort (*P*\<0.001). The rate of 30‐day readmission in patients with NAW STEMI were 7.7% in the short LOS cohort, 13.4% in the medium LOS cohort, and 19.5% in the long LOS cohort (*P*\<0.001). In the AW STEMI group, the 30‐day readmission rates were 7.8% in the very short LOS (1--2 days) cohort, 9.8% in the 3‐day LOS cohort, 13.8% in the 4‐day LOS cohort, 16.9% in the 5‐day LOS cohort, and 21.1% in the \>5‐day LOS cohort (*P*\<0.001) (Figure [2](#jah35048-fig-0002){ref-type="fig"}A). In the NAW STEMI group, the 30‐day readmission rates were 7.1% in the very short LOS cohort, 8.8% in the 3‐day LOS cohort, 12.0% in the 4‐day LOS cohort, 16.3% in the 5‐day LOS cohort, and 19.5% in the \>5‐day LOS cohort (*P*\<0.001) (Figure [2](#jah35048-fig-0002){ref-type="fig"}B). Very short LOS was associated with reduced risk of adjusted 30‐day readmission in both the AW STEMI group (adjusted HR, 0.84; 95% CI, 0.78--0.91) and the NAW STEMI group (adjusted HR, 0.87; 95% CI, 0.83--0.92) compared with 3‐day LOS. Patients with LOS of 4 days, 5 days, and \>5 days showed incrementally higher risk of adjusted 30‐day readmission in both the AW STEMI group (adjusted HR, 1.26 \[95% CI, 1.17--1.36\]; 1.42 \[95% CI, 1.30--1.55\]; and 1.50 \[95% CI, 1.39--1.63\], respectively) and the NAW STEMI group (adjusted HR, 1.19 \[95% CI, 1.11--1.27\]; 1.47 \[95% CI, 1.34--1.60\]; and 1.46 \[95% CI, 1.37--1.57\], respectively) (Figure [3](#jah35048-fig-0003){ref-type="fig"}, [Tables S3 through S8](#jah35048-sup-0001){ref-type="supplementary-material"}).

![Cumulative rates of 30‐day readmission, 30‐day mortality, 30‐day reinfarction, 30‐day repeat revascularization, and 30‐day major adverse cardiac events (MACE) according to hospital length of stay (LOS) and infarct location.\
Data show unadjusted 30‐day readmission in anterior wall (AW) ST‐segment--elevation myocardial infarction (STEMI) (**A**) and non‐AW STEMI (**B**), 30‐day readmission mortality in AW STEMI (**C**) and non‐AW STEMI (**D**), 30‐day reinfarction in AW STEMI (**E**) and non‐AW STEMI (**F**), 30‐day repeat revascularization in AW STEMI (**G**) and non‐AW STEMI (**H**), and 30‐day MACE in AW STEMI (I) and non‐AW STEMI (**J**).](JAH3-9-e015503-g002){#jah35048-fig-0002}

![Forest plot of adjusted risk of 30‐day readmission, 30‐day mortality, 30‐day reinfarction, 30‐day repeat revascularization, and 30‐day major adverse cardiac events (MACE) according to hospital length of stay (LOS) and infarct location.\
Adjusted covariates for each clinical outcome can be found in the supplemental material.](JAH3-9-e015503-g003){#jah35048-fig-0003}

Thirty‐Day Readmission Mortality, Reinfarction, and Repeat Revascularization by LOS {#jah35048-sec-0017}
-----------------------------------------------------------------------------------

The 30‐day mortality rates during readmission were 0.2% in the short LOS cohort, 0.4% in the medium LOS cohort, and 1.3% in the long LOS cohort among the AW STEMI group (*P*\<0.001), and 0.1% in the short LOS cohort, 0.4% in the medium LOS cohort, and 0.9% in the long LOS cohort among the NAW STEMI group (*P*\<0.001). The 30‐day mortality rates for both the AW STEMI group and the NAW STEMI group stratified by more detailed LOS cohorts are shown in Figure [2](#jah35048-fig-0002){ref-type="fig"}C and [2](#jah35048-fig-0002){ref-type="fig"}D. In the AW STEMI group, the rate of 30‐day mortality was the lowest in the 3‐day LOS cohort, showing a U‐shaped risk distribution (Figure [3](#jah35048-fig-0003){ref-type="fig"} and [4](#jah35048-fig-0004){ref-type="fig"}). Very short LOS after AW STEMI was associated with significantly higher risk of adjusted 30‐day mortality compared with 3‐day LOS (adjusted HR, 1.92; 95% CI, 1.16--3.16). However, the risk of adjusted 30‐day mortality increased progressively with increasing LOS (adjusted HR: 4‐day LOS \[versus 3‐day LOS\], 1.80 \[95% CI, 1.06--3.04\]; 5‐day LOS, 2.32 \[95% CI, 1.44--3.73\]; and \>5‐day LOS, 3.45 \[95% CI, 2.22--5.36\]) in the AW STEMI group. In the NAW STEMI group, the risk of adjusted 30‐day mortality was not significantly different in the very short LOS cohort (adjusted HR, 0.71; 95% CI, 0.48--1.06) versus the 3‐day LOS cohort, but the risk of adjusted 30‐day mortality sequentially increased with longer LOS (adjusted HR: 4‐day LOS \[versus 3 day LOS\], 1.52 \[95% CI, 1.00--2.30\]; 5‐day LOS, 1.76 \[95% CI, 1.06--2.93\]; and \>5‐day LOS, 2.30 \[95% CI, 1.45--3.65\]).

![Plot of 30‐day mortality according to hospital length of stay (LOS).\
**A**, Thirty‐day readmission mortality rate in patients with anterior wall (AW) ST‐segment--elevation myocardial infarction (STEMI) (red points). **B**, Thirty‐day readmission mortality rate in patients with non‐AW STEMI (red points). Box plot shows total number of patients in each LOS group.](JAH3-9-e015503-g004){#jah35048-fig-0004}

The 30‐day reinfarction rates were 4.6% in the short LOS cohort, 7.8% in the medium LOS cohort, and 10.0% in the long LOS cohort among the AW STEMI group (*P*\<0.001), and 3.8% in the short LOS cohort, 6.1% in the medium LOS cohort, and 8.0% in the long LOS cohort among the NAW STEMI group (*P*\<0.001). The 30‐day reinfarction rates for both the AW and the NAW STEMI groups stratified by the detailed LOS cohorts are shown in Figure [2](#jah35048-fig-0002){ref-type="fig"}E and [2](#jah35048-fig-0002){ref-type="fig"}F. The risk of adjusted 30‐day reinfarction increased progressively with increasing LOS in both the AW and the NAW STEMI groups (Figure [3](#jah35048-fig-0003){ref-type="fig"}).

The 30‐day revascularization rates were 2.5% in the short LOS cohort, 3.0% in the medium LOS cohort, and 2.6% in the long LOS cohort among the AW STEMI group (*P*=0.021), and 2.7% in the short LOS cohort, 3.3% in the medium LOS cohort, and 2.7% in the long LOS cohort among the NAW STEMI group (*P*\<0.001). The 30‐day repeat revascularization rates from more detailed stratification of LOS are shown in Figure [2](#jah35048-fig-0002){ref-type="fig"}G and [2](#jah35048-fig-0002){ref-type="fig"}H. There was no significant difference in the risk for adjusted 30‐day repeat revascularization among different LOS cohorts versus the 3‐day LOS cohort in both the AW STEMI and the NAW STEMI groups.

The 30‐day MACE rates were 5.8% in the short LOS cohort, 9.5% in the medium LOS cohort, and 11.9% in the long LOS cohort among the AW STEMI group (*P*\<0.001), and 5.0% in the short LOS cohort, 7.8% in the medium LOS cohort, and 9.9% in the long LOS cohort among the NAW STEMI group (*P*\<0.001). The 30‐day MACE rates for both the AW and the NAW STEMI groups stratified by the detailed LOS cohorts are shown in Figure [2](#jah35048-fig-0002){ref-type="fig"}I and [2](#jah35048-fig-0002){ref-type="fig"}J. The risk of adjusted 30‐day MACE increased progressively with increasing LOS in both the AW and the NAW STEMI groups (Figure [3](#jah35048-fig-0003){ref-type="fig"}).

Total Costs by LOS and Predictors of Total Cost {#jah35048-sec-0018}
-----------------------------------------------

Hospital costs over 30 days after index hospitalization after primary PCI for STEMI according to the LOS are shown in Table [3](#jah35048-tbl-0003){ref-type="table"}. The median cumulative costs from index hospitalization for PCI and 30‐day readmission were \$20 050 (interquartile range, \$15 494--\$27 463) in patients with AW STEMI and \$18 995 (interquartile range, \$14 790--\$25 787) in patients with NAW STEMI (*P*\<0.001). The cumulative costs were also increased in the longer LOS groups compared with the very short LOS group regardless of the location of infarct (*P*\<0.001 and *P*\<0.001, respectively).

###### 

Costs and Charges Over 30‐d Postindex Hospitalization After STEMI Stratified by the Location of Infarct

  Outcomes                                              Overall                                                          LOS 1 to 2 d              LOS 3 d                   LOS 4 d                    LOS 5 d                    LOS \>5 d                   *P* Value[a](#jah35048-note-0014){ref-type="fn"}
  ----------------------------------------------------- ---------------------------------------------------------------- ------------------------- ------------------------- -------------------------- -------------------------- --------------------------- --------------------------------------------------
  AWMI                                                                                                                                                                                                                                                         
  Patients, No.                                         187 556                                                          64 098                    53 234                    26 284                     13 947                     29 993                      
  Charge (index PCI), \$                                66 879 (48 942--96 268)[b](#jah35048-note-0015){ref-type="fn"}   56 799 (42 817--77 204)   61 581 (46 908--83 214)   69 536 (52 388--97 494)    79 591 (59 316--112 784)   110 719 (78 640--159 337)   \<0.001
  Cumulative charges (index PCI+30‐d readmission), \$   69 617 (50 272--102 446)                                         58 425 (43 741--80 277)   64 619 (47 942--87 767)   72 866 (54 208--103 595)   84 665 (61 701--120 650)   118 599 (83 336--172 750)   \<0.001
  Cost (index PCI), \$                                  19 307 (15 150--25 711)                                          16 501 (13 377--20 710)   18 166 (14 782--22 651)   20 313 (16 329--26 019)    22 821 (18 146--29 422)    31 425 (23 511--42 431)     \<0.001
  Cumulative costs (index PCI+30‐d readmission), \$     20 050 (15 494--27 463)                                          16 899 (13 609--21 627)   18 689 (15 069--23 809)   21 224 (16 890--27 804)    24 210 (19 049--31 868)    33 581 (24 883--46 152)     \<0.001
  Non‐AWMI                                                                                                                                                                                                                                                     
  No. of patients                                       351 961                                                          161 332                   97 331                    36 760                     17 947                     38 591                      
  Charge (index PCI), \$                                64 020 (47 024--91 562)                                          55 873 (42 255--75 033)   61 566 (46 898--83 430)   73 157 (54 312--102 146)   84 796 (63 283--118 509)   119 856 (84 845--171 422)   \<0.001
  Cumulative charges (index PCI+30‐d readmission), \$   66 174 (48 057--96 916)                                          57 370 (43 023--78 032)   63 462 (47 871--87 824)   76 762 (55 959--109 101)   90 277 (66 028--127 599)   126 772 (89 184--184 904)   \<0.001
  Cost (index PCI), \$                                  18 413 (14 506--24 358)                                          16 288 (13 201--20 329)   18 049 (14 630--22 707)   20 749 (16 520--26 712)    23 668 (18 782--30 667)    33 339 (24 581--45 087)     \<0.001
  Cumulative costs (index PCI+30‐d readmission), \$     18 995 (14 790--25 787)                                          16 676 (13 411--21 068)   18 576 (14 914--23 869)   21 661 (16 992--28 570)    25 055 (19 562--33 109)    35 390 (25 985--48 214)     \<0.001

AWMI indicates anterior wall myocardial infarction; LOS, length of stay; PCI, percutaneous coronary intervention; and STEMI, ST‐segment--elevation myocardial infarction.

Mann--Whitney--Wilcoxon test was used in all comparisons.

All values are shown as a median (interquartile range).
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From the multivariable hierarchical regression analysis, very short LOS was found to be associated with a 4.3% decrease in 30‐day total cost in the AW STEMI group and a 5.0% decrease in the NAW STEMI group versus 3‐day LOS. Among patients with AW STEMI, 4‐day LOS, 5‐day LOS, and \>5‐day LOS were all found to be associated with increased total costs (4.7%, 8.6%, and 19.0% increase, respectively; *P*\<0.001 for all) versus 3‐day LOS (Table [4](#jah35048-tbl-0004){ref-type="table"}). Similarly, 4‐day LOS, 5‐day LOS, and \>5‐day LOS were associated with increased total costs (5.8%, 10.7%, and 22.3% increase, respectively; *P*\<0.001 for all) compared with 3‐day LOS in the NAW STEMI cohort. The 30‐day readmission was a significant predictor of increased total costs in both the AW STEMI group (17.5% increase, *P*\<0.001) and the NAW STEMI group (18.7% increase, *P*\<0.001).

###### 

Multivariate Regression Analysis to Assess the Association of LOS on Total Cost in Patients With STEMI Stratified by the Location of Infarct

  Variable                                              AW STEMI   Non‐AW STEMI                                             
  ----------------------------------------------------- ---------- ------------------ --------- -------- ------------------ ---------
  LOS (reference: 3 d)                                                                                                      
  1 to 2 d                                              −0.043     −0.049 to −0.037   \<0.001   −0.050   −0.055 to −0.046   \<0.001
  4 d                                                   0.047      0.043--0.052       \<0.001   0.058    0.055--0.062       \<0.001
  5 d                                                   0.086      0.080--0.091       \<0.001   0.107    0.102--0.112       \<0.001
  \>5 d                                                 0.190      0.185--0.196       \<0.001   0.223    0.218--0.228       \<0.001
  30‐d readmission                                      0.175      0.170--0.180       \<0.001   0.187    0.183--0.191       \<0.001
  Age (reference: \<50), y                                                                                                  
  50 to 64                                              0.006      0.003--0.010       0.001     0.007    0.004--0.010       \<0.001
  \>64                                                  0.007      0.002--0.013       0.006     0.010    0.006--0.014       \<0.001
  Women (reference: men)                                −0.018     −0.021 to −0.015   \<0.001   −0.019   −0.022 to −0.017   \<0.001
  Diabetes mellitus                                     0.004      0.001--0.007       0.012     0.005    0.002--0.007       \<0.001
  Dyslipidemia                                          n/s                                     0.004    0.001--0.007       0.014
  Previous MI                                           0.009      0.004--0.015       0.001     n/s                         
  Known coronary artery disease                         0.008      0.002--0.013       0.005     0.008    0.003--0.012       0.001
  Peripheral vascular disease                           0.010      0.004--0.016       0.002     0.005    0.001--0.009       0.017
  Chronic kidney disease                                n/s                                     −0.010   −0.015 to −0.006   \<0.001
  Anemia                                                0.006      0.001--0.012       0.030     n/s                         
  Coagulopathy                                          0.031      0.023--0.040       \<0.001   0.029    0.022--0.036       \<0.001
  Drug abuse                                            0.012      0.003--0.020       0.006     n/s                         
  Fluid/electrolyte disorders                           0.012      0.007--0.017       \<0.001   0.011    0.007--0.016       \<0.001
  Obesity                                               0.013      0.008--0.018       \<0.001   0.010    0.006--0.013       \<0.001
  Cardiogenic shock                                     0.029      0.022--0.036       \<0.001   0.029    0.024--0.035       \<0.001
  Cardiac arrest                                        0.050      0.042--0.057       \<0.001   0.037    0.031--0.043       \<0.001
  IABP                                                  0.077      0.071--0.084       \<0.001   0.080    0.073 to 0.087     \<0.001
  PLVAD                                                 0.288      0.262--0.314       \<0.001   0.291    0.267--0.314       \<0.001
  Weekend admission                                     n/s                                     0.005    0.003--0.008       \<0.001
  Median household income (reference: first quartile)                                                                       
  Second quartile                                       0.020      0.014--0.025       \<0.001   0.021    0.015--0.026       \<0.001
  Third quartile                                        0.038      0.030--0.045       \<0.001   0.035    0.028--0.041       \<0.001
  Fourth quartile                                       0.064      0.055--0.074       \<0.001   0.064    0.055--0.073       \<0.001
  Primary payer (reference: Medicare)                                                                                       
  Medicaid                                              0.018      0.010--0.025       \<0.001   0.011    0.005--0.017       \<0.001
  Private                                               0.015      0.010--0.020       \<0.001   0.014    0.010--0.017       \<0.001
  Self‐pay/no charge/others                             0.002      −0.004 to 0.008    0.568     −0.002   −0.007 to 0.003    0.534
  Hospital bed size (reference: small)                                                                                      
  Medium                                                −0.023     −0.050 to 0.003    0.078     −0.018   −0.043 to 0.007    0.156
  Large                                                 −0.033     −0.059 to −0.008   0.011     −0.031   −0.056 to −0.007   0.013
  Disposition (reference: home)                                                                                             
  Facility                                              0.017      0.011--0.022       \<0.001   0.010    0.006--0.015       \<0.001
  AMA/unknown                                           −0.010     −0.029 to 0.008    0.261     −0.009   −0.021 to −0.003   0.140
  Year (per y)                                          0.008      0.003--0.014       0.004     0.008    0.003--0.013       0.004

AMA indicates against medical advice; AW, anterior wall; IABP, intra‐aortic balloon pump; LOS, length of stay; MI, myocardial infarction; PLVAD, percutaneous left ventricular assist device; and STEMI, ST‐segment--elevation myocardial infarction.

Survey‐specific multivariate linear regression model was created with an outcome of log‐transformed cumulative cost including all predictors with *P*\<0.1 in the univariate analysis. Hospital ID was also included as a covariable for consideration of hospital fixed‐year effect (insignificant contribution, not shown).
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Discussion {#jah35048-sec-0019}
==========

In this large, contemporary, all‐payer observational analysis of the NRD, we have presented several noteworthy findings for patients with STEMI who underwent primary PCI. First, very short LOS after primary PCI for STEMI was associated with significantly less 30‐day readmission with reduced overall costs compared with more traditional, longer LOS in all STEMI groups. Second, very short LOS appeared to be associated with higher 30‐day readmission mortality rate compared with an LOS of at least 3 days in patients with AW STEMI, while very short LOS was associated with similar 30‐day readmission mortality to 3‐day LOS in patients with NAW STEMI. Third, rates of 30‐day reinfarction, repeat revascularization rate, and MACE were the lowest in the very short LOS cohort.

Reducing hospital LOS has become a top priority in the past decade for our healthcare systems in the United States.[21](#jah35048-bib-0021){ref-type="ref"}, [22](#jah35048-bib-0022){ref-type="ref"} Hospitalization with an average LOS of 4.5 days is estimated to cost the healthcare industry \$377.5 billion annually, and longer LOS has contributed greatly to these rising healthcare costs.[23](#jah35048-bib-0023){ref-type="ref"} Optimizing and reducing LOS improves financial, operational, and clinical outcomes by preventing unnecessary hospital stays and decreasing the costs of care for a patient in various conditions.[24](#jah35048-bib-0024){ref-type="ref"}, [25](#jah35048-bib-0025){ref-type="ref"} With recent advances in medical therapy and various therapeutic modalities, outcomes after STEMI have steadily improved over the past several years.[1](#jah35048-bib-0001){ref-type="ref"}, [26](#jah35048-bib-0026){ref-type="ref"} With improving outcomes, there has been a growing interest in shortening LOS and assessing feasibility of early discharge after primary PCI for STEMI.[27](#jah35048-bib-0027){ref-type="ref"}, [28](#jah35048-bib-0028){ref-type="ref"} We previously reported that short LOS (1--3 days) resulted in similar 30‐day outcomes compared with medium LOS (4--5 days) after primary PCI for STEMI in the Medicare population using the NCDR (National Cardiovascular Data Registry) from 2004 to 2009.[9](#jah35048-bib-0009){ref-type="ref"} However, very short LOS (1--2 days) was associated with worse 30‐day mortality and 30‐day MACE in this elderly population. In the current study, analyzing all comers, including younger population with more contemporary data from 2010 to 2014, we demonstrated that very short hospital stay is associated with significantly less 30‐day readmission as well as 30‐day MACE including reinfarction and repeat revascularization. Shorter LOS and lower readmission rates were associated with 4.3% to 5.0% reduction in overall costs compared with more traditional ≥3 day LOS. However, very short LOS in AW STEMI was associated with an ≈2‐fold increase in 30‐day mortality, while very short LOS was not associated with any increase in adverse outcomes in the NAW STEMI group. In fact, very short LOS was associated with 13% reduction in readmission rates and an ≈5.0% reduction in overall costs in comparison to 3‐day LOS in the NAW STEMI cohort. Our data emphasize that a very early discharge strategy for low‐risk patients can be safe and feasible, especially in those with NAW STEMI. However, more careful assessment is necessary for patients with AW STEMI before opting for very early discharge. Once patients with AW STEMI are readmitted after a very short LOS during the index hospitalization, they may need closer attention with their medical care as our study demonstrates a higher 30‐day mortality rate once they are readmitted. Our finding is not surprising given the increased likelihood of developing heart failure, left ventricular thrombus, and other complications including ventricular septal wall defect and free wall rupture, with AW STEMI because of larger territory involved.[29](#jah35048-bib-0029){ref-type="ref"}, [30](#jah35048-bib-0030){ref-type="ref"} This group of patients may require more time to optimize the medications, especially for potentially newly developed heart failure with reduced ejection fraction.

Despite recent studies demonstrating the safety of very early discharge after PCI,[6](#jah35048-bib-0006){ref-type="ref"}, [7](#jah35048-bib-0007){ref-type="ref"}, [8](#jah35048-bib-0008){ref-type="ref"}, [9](#jah35048-bib-0009){ref-type="ref"}, [31](#jah35048-bib-0031){ref-type="ref"} a significant portion of patients stay in the hospital ≥3 days in the real world as demonstrated in our study (58.2%). Studies performed before modernization of pharmacotherapy and interventional therapy have demonstrated risks of potential subacute complications up to 72 hours after STEMI,[32](#jah35048-bib-0032){ref-type="ref"} which has become a foundation of our clinical practice for many years. However, recent studies including the current one demonstrate the safety of early discharge in certain low‐risk cohorts. A recent increase in the adoption of radial access certainly has contributed to a significant decrease in access site complications and bleeding risk,[33](#jah35048-bib-0033){ref-type="ref"} which, in turn, may contribute to improving in‐hospital outcomes with shorter LOS.[33](#jah35048-bib-0033){ref-type="ref"}, [34](#jah35048-bib-0034){ref-type="ref"}, [35](#jah35048-bib-0035){ref-type="ref"}, [36](#jah35048-bib-0036){ref-type="ref"} With a recent study showing a significant increase of transradial PCI from 2010 to 2012 in the United States,[37](#jah35048-bib-0037){ref-type="ref"}, [38](#jah35048-bib-0038){ref-type="ref"} reduced readmission in the very short LOS cohort in our study may partially reflect more contemporary data in the current era of transradial PCI.

Since the implementation of the HRRP, there have been some controversies on the association of reduction in readmission rates and its impact on overall mortality.[39](#jah35048-bib-0039){ref-type="ref"}, [40](#jah35048-bib-0040){ref-type="ref"} A study comprising Medicare beneficiaries with heart failure demonstrated that the implementation of the HRRP was associated with an 0.5% increase in 30‐day mortality.[41](#jah35048-bib-0041){ref-type="ref"}, [42](#jah35048-bib-0042){ref-type="ref"} Some studies have shown that 30‐day readmission rate has a poor or even an inverse relationship with 30‐day mortality.[43](#jah35048-bib-0043){ref-type="ref"}, [44](#jah35048-bib-0044){ref-type="ref"} Pandey et al[45](#jah35048-bib-0045){ref-type="ref"} demonstrated that the 30‐day risk‐adjusted readmission rates after acute myocardial infarction were not associated with 1‐year mortality. In addition, Dharmarajan et al[46](#jah35048-bib-0046){ref-type="ref"} reported that the reduction in 30‐day readmission rate did not correlate with higher 30‐day mortality rate in Medicare beneficiaries hospitalized for acute myocardial infarction. The inverse relationship of 30‐day readmission and 30‐day mortality in the AW STEMI group with very short LOS in our study demonstrates that 30‐day readmission rate may not be the best metric for quality of care, especially for AW STEMI. More detailed studies are necessary to tease out the features that may predispose certain patients with STEMI who would be at risk of worse outcomes with very early discharge. Last, our study demonstrated that the total cumulative costs are the lowest in the very short LOS group in both the patients with AW and NAW STEMI, mostly as a result of significantly less index hospitalization cost with similar or fewer readmissions. Identifying proper cohorts with less likelihood of readmission despite shortening the LOS remains an important goal for future studies.

Study Limitations {#jah35048-sec-0020}
=================

The present study has the limitations inherent to nonrandomized observational studies. First, the data from the NRD include the sample designed to approximate the national distribution of representative hospital characteristics. Our study cohort was derived from approximately half sample of US hospitals, and as a result the study cohort can be either underrepresented or overrepresented by the sample. Our results cannot be considered completely generalizable among all states in the United States since the NRD includes only 22 states in the United States. However, there have been numerous publications utilizing the NRD that validate the sampling design.[15](#jah35048-bib-0015){ref-type="ref"}, [47](#jah35048-bib-0047){ref-type="ref"}, [48](#jah35048-bib-0048){ref-type="ref"} Second, the study cohort from a large administrative data set can be subject to coding bias or possibly missing events or variables. Nevertheless, many studies have proven the validity of using administrative databases for risk‐adjusted outcome evaluation.[47](#jah35048-bib-0047){ref-type="ref"}, [49](#jah35048-bib-0049){ref-type="ref"}, [50](#jah35048-bib-0050){ref-type="ref"} Third, some of the clinical parameters including vital signs (eg, blood pressure and heart rate), echocardiographic parameters (eg, ejection fraction), laboratory findings (eg, troponin‐I and brain natriuretic peptide), or medications (eg, antiplatelets and heart failure medications) are not available for analysis in the NRD. Our study is intended to generate a hypothesis, and future studies are necessary to confirm our findings with more detailed information. Fourth, although we performed an appropriate statistical approach using validated risk models, there is no way to eliminate bias from the influence of unmeasured confounders given that the NRD is based on *ICD‐9‐CM* codes. Fifth, our study did not differentiate between STEMI with emergent PCI versus STEMI with delayed PCI during hospitalization. In addition, some of the readmissions may be attributable to staged PCI procedures, but the limitation of the database does not allow identification of these admissions. Sixth, our cost analyses did not consider the effects of differential mortality among different LOS cohorts. Finally, our 30‐day mortality rate does not account for out‐of‐hospital deaths, which may underestimate the overall mortality rate.

Conclusions {#jah35048-sec-0021}
===========

This study examined short‐term clinical outcomes and total costs according to LOS after STEMI stratified by the location of infarct. Our data show that very early discharge after primary PCI is safe and less costly in low‐risk patients, especially those with NAW STEMI. For those with AW STEMI, care needs to be taken before opting for very early discharge given the potential increase in 30‐day mortality. Very short LOS is associated with fewer readmissions, but if patients are readmitted, 30‐day mortality is higher in those with AW STEMI. Further studies to better identify proper cohorts of patients with STEMI who are suitable for a very early discharge strategy are warranted. These efforts will hopefully lead to reduction in overall cost and improvement in overall quality and efficiency of care for patients with STEMI.
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